Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS

References

• Masclans J, Roca O, Muñoz X, et al. Quality of life, pulmonary function, and tomographic scan abnormalities after ARDS. Chest. 2011;139:1340–1346.
   PubMed Web of Science ®Google Scholar
• Heyland D, Groll D, Caeser M. Survivors of acute respiratory distress syndrome: Relationship between pulmonary dysfunction and long-term health-related quality of life*. Crit Care Med. 2005;33:1549–1556.
   PubMed Web of Science ®Google Scholar
• Ngai JC, Ko FW, Ng SS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543–550.
   PubMed Web of Science ®Google Scholar
• Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020;52, jrm00063.
   PubMed Web of Science ®Google Scholar
• Hui D, Joynt G, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401–409.
   PubMed Web of Science ®Google Scholar
• González J, Benítez ID, Carmona P, et al. Pulmonary function and radiologic features in survivors of critical COVID-19. Chest. 2021;160:187–198.
   PubMed Web of Science ®Google Scholar
• van Gassel RJJ, Bels JLM, Raafs A, et al. High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. Am J Respir Crit Care Med. 2021;203:371–374.
   PubMed Web of Science ®Google Scholar
• Blanco JR, Cobos-Ceballos MJ, Navarro F, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021;27(6):892–896.
   PubMed Web of Science ®Google Scholar
• Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397:220–232.
   PubMed Web of Science ®Google Scholar
• Guler S, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(2003690.
   PubMedGoogle Scholar
• Sibila O, Albacar N, Perea L, et al. Lung function sequelae in COVID-19 patients 3 months after hospital discharge. Arch Bronconeumol. 2021;57:59–61.
   PubMed Web of Science ®Google Scholar
• García-Hidalgo MC, González J, Benítez ID, et al. Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2–induced ARDS. Clin Transl Med. 2022;12(5):e838.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Roles for MicroRNAs in conferring robustness to biological processes. Cell Elsevier B.V. 2012: 515–524.
   Google Scholar
• Mendell J, Olson E. Micrornas in stress signaling and human disease. Cell. 2012;148:1172–1187.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Parkin R, Kroh E, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Mori M, Ludwig R, Garcia-Martin R, et al. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab 2019;30:656–673.
   PubMed Web of Science ®Google Scholar
• Cheng M, Yang J, Zhao X, et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat Commun. 2019;10:959.
   PubMed Web of Science ®Google Scholar
• Gomez I, Ward B, Souilhol C, et al. Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium. Nat Commun. 2020;11:214.
   PubMed Web of Science ®Google Scholar
• Holtzman J, Lee H. Emerging role of extracellular vesicles in the respiratory system. Exp Mol Med. 2020;52:887–895.
   PubMed Web of Science ®Google Scholar
• Torres A, Arguimbau M, Bermejo-Martín J, et al. Ciberesucicovid: un proyecto estratégico para una mejor comprensión y manejo clínico de la COVID-19 en pacientes críticos. Arch Bronconeumol. 2021;57:1–2.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA - J Am Med Assoc. 2012;307:2526–2533.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
   PubMed Web of Science ®Google Scholar
• Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Eur Respir J. 1998;11:1354–1362.
   PubMed Web of Science ®Google Scholar
• Ooi GC, Khong PL, Müller NL, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004;230:836–844.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809–815.
   PubMed Web of Science ®Google Scholar
• de Gonzalo-Calvo D, Benítez ID, Pinilla L, et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl Res. 2021;S1931-5244:00122–00125.
   Google Scholar
• Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods Academic Press Inc. 2013: S1–S6.
   Google Scholar
• Vlachos IS, Zagganas K, Paraskevopoulou MD, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Web Serv Issue Publ Online. 2015;43.
   Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47.
   PubMed Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn. 2001;45:5–32.
   Web of Science ®Google Scholar
• Genuer R, Poggi JM, Tuleau-Malot C. Variable selection using random forests. Pattern Recognit Lett. 2010;31:2225–2236.
   Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Sparse inverse covariance estimation with the graphical lasso. Biostatistics. 2008;9:432–441.
   PubMed Web of Science ®Google Scholar
• Baek D, Villén J, Shin C, et al. The impact of microRNAs on protein output. Nature. 2008;455:64–71.
   PubMed Web of Science ®Google Scholar
• Barbagallo D, Palermo CI, Barbagallo C, et al. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells. Cell Mol Life Sci. 2022;79:75.
   PubMed Web of Science ®Google Scholar
• Miska EA, Alvarez-Saavedra E, Abbott AL, et al. Most caenorhabditis elegans microRNAs Are individually Not essential for development or viability. PLOS Genet. 2007;3:e215.
   PubMed Web of Science ®Google Scholar
• Fierro-Fernández M, Busnadiego Ó, Sandoval P, et al. Mir-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX 4 and TGFBR 2. EMBO Rep 2015;16:1358–1377.
   PubMed Web of Science ®Google Scholar
• Chun HJ, Coutavas E, Pine AB, et al. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. 2021;6:e148476.
   PubMed Web of Science ®Google Scholar
• Kheirollahi V, Wasnick RM, Biasin V, et al. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis. Nat Commun. 2019;10:1–16.
   PubMed Web of Science ®Google Scholar
• Gokey JJ, Sridharan A, Xu Y, et al. Active epithelial hippo signaling in idiopathic pulmonary fibrosis. JCI Insight. 2018;3:e98738.
   PubMed Web of Science ®Google Scholar
• Platé M, Guillotin D, Chambers RC. The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis. Eur Respir Rev. 2020;29:200269.
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang K-J, et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci. 2006;103:12481–12486.
   PubMed Web of Science ®Google Scholar
• McElvaney OJ, McEvoy NL, McElvaney OF, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202:812–821.
   PubMed Web of Science ®Google Scholar
• Heywood WE, Doykov I, Hällqvist J, et al. ‘The long tail of COVID-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349.
   PubMedGoogle Scholar
• Wang J, Huang R, Xu Q, et al. Mesenchymal stem cell-derived extracellular vesicles alleviate acute lung injury Via transfer of miR-27a-3p∗. Crit Care Med. 2020;48:E599–E610.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Crit Care. 2019;23:44.
   PubMed Web of Science ®Google Scholar
• Malas MB, Naazie IN, Elsayed N, et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29-30:100639.
   Google Scholar
• Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136:1347.
   PubMed Web of Science ®Google Scholar
• Kanso M, Cardi T, Marzak H, et al. Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur Hear J - Case Reports. 2020;4:1–4.
   PubMedGoogle Scholar
• Xiong Y, Liu Y, Cao L, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect. 2020;9:761–770.
   PubMed Web of Science ®Google Scholar
• Cao D, Mikosz AM, Ringsby AJ, et al. MicroRNA-126-3p inhibits angiogenic function of human lung microvascular endothelial cells via LAT1 (L-type amino acid transporter 1)-mediated mTOR (mammalian target of rapamycin) signaling. Arterioscler Thromb Vasc Biol. 2020;40:1195–1206.
   PubMed Web of Science ®Google Scholar
• Katira BH, Giesinger RE, Engelberts D, et al. Adverse heart–lung interactions in ventilator-induced lung injury. Am J Respir Crit Care Med. 2017;196:1411–1421.
   PubMed Web of Science ®Google Scholar
• Salamanna F, Veronesi F, Martini L, et al. Post-COVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021;0:392.
   Google Scholar
• Pinilla L, Benitez ID, González J, et al. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points. RNA Biol.; 2021. p. 688–695.
   Google Scholar